SandraMetaSwainMD
Oncology • Washington, DCProfessor, Medicine, Georgetown University School of Medicine
Dr. Swain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
120 37th St NW
Washington, DC 20057Phone+1 202-687-8487- Is this information wrong?
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1983 - 1986
Vanderbilt University Medical CenterResidency, Internal Medicine, 1980 - 1983
University of Florida College of MedicineClass of 1980
Certifications & Licensure
MD State Medical License 1983 - 2025
TX State Medical License 1996 - 2024
DC State Medical License 1988 - 2024
IL State Medical License 1989 - 2014- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Ixabepilone in Treating Patients With Locally Advanced or Metastatic Breast Cancer Start of enrollment: 2002 May 01
- Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer Start of enrollment: 2004 Oct 01
- Solid Tumors Using Ixabepilone and Dasatinib Start of enrollment: 2008 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsAccessibility of clinical study reports supporting medicine approvals: a cross-sectional evaluation.Ashley M Hopkins, Natansh D Modi, Frank W Rockhold, Tammy Hoffmann, Bradley D Menz, Areti-Angeliki Veroniki, Ross A McKinnon, Andrew Rowland, Sandra M Swain, Joseph S ...> ;Journal of Clinical Epidemiology. 2024 Mar 1
- Real-World First-Line Use of Pertuzumab With Different Taxanes for Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Comparative Effectiven...Letizia Polito, Jinjoo Shim, Sara A Hurvitz, Chau T Dang, Adam Knott, Yolande Du Toit, Eleonora Restuccia, Thibaut Sanglier, Sandra M Swain> ;JCO Oncology Practice. 2023 Jul 1
- 1 citationsPost-CDK 4/6 Inhibitor Therapy: Current Agents and Novel Targets.Nadia Ashai, Sandra M Swain> ;Cancers. 2023 Mar 20
- Join now to see all
Journal Articles
- Left Ventricular Ejection Fraction Monitoring Adherence RatesChau T Dang, Sandra M Swain, Anne Blaes, ScienceDirect
- Take Care of Your NeighborhoodElmer E Huerta, Sandra M Swain, Breast Cancer Research and Treatment
Lectures
- NSABP B-41, a randomized neoadjuvant trial: Genes and signatures associated with pathologic complete response (pCR).2019 ASCO Annual Meeting - 6/1/2019
- End-of-study analysis from the phase III, randomized, double-blind, placebo (Pla)-controlled CLEOPATRA study of first-line (1L) pertuzumab (P), trastuzumab (H), and do...2019 ASCO Annual Meeting - 6/1/2019
- Intrinsic subtypes of HER2-positive breast cancer and their associations with pathologic complete response (pCR) and outcomes: Findings from NSABP B-41, a randomized n...2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
- Join now to see all
Press Mentions
NanoString Announces the Creation of the GeoMx Breast Cancer ConsortiumDecember 11th, 2019
During Breast Cancer Awareness Month, Don’t Forget to Check the Heart!October 18th, 2019
Long-Term Data Continue to Support Perjeta Regimen for HER2-Positive Metastatic Breast CancerJune 7th, 2019- Join now to see all
Grant Support
- Inflammatory Breast CancerNational Cancer Institute2007
- Developmental TherapeuticsNational Cancer Institute2007
- Breast Cancer PreventionNational Cancer Institute2007
- Adjuvant Therapy Of Breast CancerNational Cancer Institute2007
- Breast Cancer PreventionDivision Of Basic Sciences - Nci2006
- Adjuvant Therapy Of Breast CancerDivision Of Basic Sciences - Nci2005–2006
- Developmental TherapeuticsDivision Of Basic Sciences - Nci2001–2006
- Inflammatory Breast CancerDivision Of Clinical Sciences - Nci2000–2006
Hospital Affiliations
MedStar Washington Hospital CenterWashington, District of Columbia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
